NEW CRYSTALLINE DIPHENYL ACETIDINONE HYDRATE, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUND AND USE THEREOF

Crystalline dodecanedioic acid 4-[(2S,3R)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-2-(4-methoxy-phenyl)-4-oxo-azetidin-1-yl]-benzylamide ((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxy-hexyl)-amide (A) in hydrate form (I), is new. Crystalline dodecanedioic acid 4-[(2S,3R)-3-[(S)-3-(4-fluoro-phenyl)-3-hydr...

Full description

Saved in:
Bibliographic Details
Main Authors WOLLMANN, THEODOR ANDREAS, CULLMANN, FRANK, DUFFY, REGINA
Format Patent
LanguageEnglish
French
German
Published 25.08.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Crystalline dodecanedioic acid 4-[(2S,3R)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-2-(4-methoxy-phenyl)-4-oxo-azetidin-1-yl]-benzylamide ((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxy-hexyl)-amide (A) in hydrate form (I), is new. Crystalline dodecanedioic acid 4-[(2S,3R)-3-[(S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl]-2-(4-methoxy-phenyl)-4-oxo-azetidin-1-yl]-benzylamide ((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxy-hexyl)-amide (A) in hydrate form of formula (I), is new. n : 0.5-1.8, preferably 1-1.2. Independent claims are included for: (1) a medicament comprising (I); and (2) the preparation of (I). [Image] ACTIVITY : Antilipemic. MECHANISM OF ACTION : None given.
Bibliography:Application Number: EP20080850642